BMC Cancer (2021) 21:549 https://doi.org/10.1186/s12885-021-08323-4 RESEARCH Open Access Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small- cell lung cancer: a pooled analysis of 6 randomized trials Piera Gargiulo1†, Laura Arenare1†, Cesare Gridelli2, ...
The Chemotherapy-Induced Neutropenia (CIN) Treatment Market is expected to reach USD 651.26 million in 2025 and grow at a CAGR of 3.58% to reach USD 776.49 million by 2030. Amgen, Inc., Teva Pharmaceuticals Industries Ltd., BeyondSpring Pharmaceuticals I
The association of chemotherapy induced neutropenia on treatment outcomes in small cell lung cancer[J] . Udai Banerji,Sue Ashley,Jim Coward,Sarah Hughes,Ying Zee,Taqdir Benepal,Alison Norton,Tim Eisen,Mary O’Brien.Lung Cancer . 2006 (3)...
This report lists the top Chemotherapy-Induced Neutropenia (CIN) Treatment companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Chemotherapy-Induced Neutropenia (CIN) Treatment ...
Chemotherapy-induced neutropenia (CIN) is a common adverse occurrence in patients treated for solid tumors. Pharmacists who often see CIN will find a review published ahead-of-print inExpert Opinion on Pharmacotherapyenlightening. This paper emphasized optimal implementation of outpatient treatment and the...
Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of 6 randomized trials Article Open access 14 May 2021 Chemotherapy-induced neutropenia as a prognostic factor in patients with pancreatic cancer treated with gemcitabine plus nab-paclitaxe...
Chemotherapy-induced neutropenia (CIN) is a common adverse event during treatment of cancer patients, associated with increased morbidity, mortality, health care costs and impairment of patients' quality of life which necessitate dose reductions.A computerized systematic literature search was performed ...
Chemotherapy is among the standard treatments for cancer but neutropenia and febrile neutropenia are the most common side effects. Objective: To assess the incidences of chemotherapy-induced neutropenia, febrile-neutropenia and associated factors in solid cancer patients attending Oncology unit of St. ...
relationship between severity and duration of chemotherapy-induced neutropenia and risk of infection among patients with.化疗所致嗜中性白血球减少症的严重程度和持续时间之间的关系和感 热度: Treatment of chemotherapy-induced neutropenia in a rat model by using multiple daily doses of oral administration of...
Chemotherapy-induced neutropenia has been shown to be associated with improved treatment outcomes in various solid tumor types. We looked to summarize the relationship between chemotherapy-induced neutropenia and survival in patients with breast, ovarian and cervical cancer and describe future directions of...